Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B

NCT01311947 · clinicaltrials.gov ↗

COMPLETED

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Peginterferon alfa-2a

Sponsor

China Medical University Hospital